Belonging to the same group of autoimmune diseases, both dermatomyositis and polymyositis cause muscle inflammation and weakness. But dermatomyositis also affects your skin and is more likely to ...

ANAHEIM, Calif., Sept. 13, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that the company will be teaming up with The Myositis Association (TMA) to support ...

Among systemic rheumatic diseases, the risk for opportunistic infection is highest among patients with polymyositis or dermatomyositis, followed by systemic lupus erythematosus, systemic sclerosis, ...

The clinical spectrum of idiopathic inflammatory myopathies (IIMs) has evolved from diseases in which muscle weakness was the main manifestation to systemic inflammatory diseases with multiple organ ...

Statin initiation rates were considerably lower among patients with dermatomyositis/polymyositis with hyperlipidemia than in those with rheumatoid arthritis with ...

Nearly one-third of PM/DM patients are readmitted within 180 days. Common causes of readmission include PM exacerbations and sepsis. Female patients, obese patients, patients with comorbid conditions, ...

SEOUL, South Korea, Oct. 17, 2023 /PRNewswire/ -- ImmunoForge today announced that it has dosed the first patient in its Phase 2 clinical trial to evaluate the efficacy, safety, and pharmacokinetic ...

CORONA, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Patients with dermatomyositis or ...

SAN FRANCISCO--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic ...

SAN FRANCISCO--(BUSINESS WIRE)-- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic ...